Opioid Crisis

All 50 states agree to OxyContin maker Purdue Pharma’s plan for Sackler family to pay up to $7 billion to settle opioid epidemic lawsuits
Finance

All 50 states agree to OxyContin maker Purdue Pharma’s plan for Sackler family to pay up to $7 billion to settle opioid epidemic lawsuits

By Geoff Mulvihill and The Associated Press
June 18, 2025
Purdue Pharma makes new offer to settle lawsuits over Oxycontin opioid crisis, and it includes up to $7 billion cash from the Sacklers
Finance

Purdue Pharma makes new offer to settle lawsuits over Oxycontin opioid crisis, and it includes up to $7 billion cash from the Sacklers

By Geoff Mulvihill and The Associated Press
March 19, 2025
China says U.S. owes ‘big thank you’ on fentanyl, urges talks
Politics

China says U.S. owes ‘big thank you’ on fentanyl, urges talks

By
March 13, 2025
Canada appoints former Mountie as fentanyl czar as part of deal with Trump to avoid 25% tariffs
Politics

Canada appoints former Mountie as fentanyl czar as part of deal with Trump to avoid 25% tariffs

By
February 12, 2025
Mexican flag waving
Politics

How do Mexico, Canada, and China affect fentanyl flowing into the U.S.?

By The Associated Press and Jesse Bedayn
February 4, 2025
Close-up view of man in blue button-down shirt placing pills in his hand.
Health

New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids

By Bloomberg and Gerry Smith
January 31, 2025
Purdue Pharma and Sackler family to pay $7.4 billion in revised settlement of lawsuits over OxyContin opioid toll
Health

Purdue Pharma and Sackler family to pay $7.4 billion in revised settlement of lawsuits over OxyContin opioid toll

By Geoff Mulvihill and The Associated Press
January 24, 2025
Kentucky reaches $110 million deal with Kroger to settle its opioid lawsuit—‘This massive grocery chain…allowed the fire of addiction to spread’
Retail

Kentucky reaches $110 million deal with Kroger to settle its opioid lawsuit—‘This massive grocery chain…allowed the fire of addiction to spread’

By
January 10, 2025
Ohio Supreme Court says counties can’t sue pharmacy chains in decision that could overturn a $650 million opioid judgment
Health

Ohio Supreme Court says counties can’t sue pharmacy chains in decision that could overturn a $650 million opioid judgment

By Julie Carr Smyth and The Associated Press
December 11, 2024
A person stands outside of the Supreme Court holding a sign which reads "The Sacklers destroyed my parent's lives."
Politics

The Supreme Court just rejected a deal with the maker of OxyContin that would have shielded the billionaire Sackler family from liability—but provided billions of dollars to fight opioids

By The Associated Press and Mark Sherman
June 27, 2024
Arkansas is suing pharmacy benefit managers Express Scripts and Optum, accusing them of fueling the state’s opioid crisis
Health

Arkansas is suing pharmacy benefit managers Express Scripts and Optum, accusing them of fueling the state’s opioid crisis

By Andrew DeMillo and The Associated Press
June 25, 2024
Gavin Newsom
Politics

Frustrated by high drug prices, California will offer its own version of heavily discounted Narcan to stop fentanyl overdoses

By Adam Beam and The Associated Press
April 29, 2024
OxyContin marketer and opioid maker announce $500m in settlements to avoid trials on their responsibility for crisis
Health

OxyContin marketer and opioid maker announce $500m in settlements to avoid trials on their responsibility for crisis

By Geoff Mulvihill and The Associated Press
February 2, 2024
EBay will pay $59m settlement over pill presses sold on the site—the kind used to make counterfeit pills laced with fentanyl
Health

EBay will pay $59m settlement over pill presses sold on the site—the kind used to make counterfeit pills laced with fentanyl

By Lindsay Whitehurst and The Associated Press
February 1, 2024
Bob Ferguson
Health

‘They knew what the harm was. They did it anyway’: Johnson & Johnson pays $149.5 million to Washington state over opioids

By Manuel Valdes, Hallie Golden and The Associated Press
January 24, 2024

Most Popular